1. Home
  2. DCTH vs WBX Comparison

DCTH vs WBX Comparison

Compare DCTH & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • WBX
  • Stock Information
  • Founded
  • DCTH 1988
  • WBX 2015
  • Country
  • DCTH United States
  • WBX Spain
  • Employees
  • DCTH N/A
  • WBX N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • WBX Industrial Specialties
  • Sector
  • DCTH Health Care
  • WBX Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • WBX Nasdaq
  • Market Cap
  • DCTH 485.5M
  • WBX 102.7M
  • IPO Year
  • DCTH N/A
  • WBX N/A
  • Fundamental
  • Price
  • DCTH $12.38
  • WBX $6.40
  • Analyst Decision
  • DCTH Strong Buy
  • WBX Buy
  • Analyst Count
  • DCTH 4
  • WBX 3
  • Target Price
  • DCTH $24.00
  • WBX $14.33
  • AVG Volume (30 Days)
  • DCTH 795.5K
  • WBX 26.8K
  • Earning Date
  • DCTH 08-04-2025
  • WBX 07-31-2025
  • Dividend Yield
  • DCTH N/A
  • WBX N/A
  • EPS Growth
  • DCTH N/A
  • WBX N/A
  • EPS
  • DCTH N/A
  • WBX N/A
  • Revenue
  • DCTH $53,850,000.00
  • WBX $171,352,140.00
  • Revenue This Year
  • DCTH $155.42
  • WBX N/A
  • Revenue Next Year
  • DCTH $37.93
  • WBX $44.10
  • P/E Ratio
  • DCTH N/A
  • WBX N/A
  • Revenue Growth
  • DCTH 1068.87
  • WBX 3.75
  • 52 Week Low
  • DCTH $7.17
  • WBX $4.60
  • 52 Week High
  • DCTH $18.23
  • WBX $32.80
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 32.85
  • WBX 96.07
  • Support Level
  • DCTH $12.11
  • WBX $0.29
  • Resistance Level
  • DCTH $14.15
  • WBX $5.99
  • Average True Range (ATR)
  • DCTH 0.59
  • WBX 0.14
  • MACD
  • DCTH -0.20
  • WBX 0.71
  • Stochastic Oscillator
  • DCTH 10.52
  • WBX 100.00

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.

Share on Social Networks: